branchenspezifische Dividenden NATCO Pharma Limited
Aktien
A2ABRD
INE987B01026
NATCOPHARM
Pharmazeutika
|
Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | Veränd. 1. Jan. | ||
| 917.55 INR | +5.77% |
|
-1.91% | -33.86% |
| 02.12. | NATCO Pharma Limited kündigt Veränderungen im Führungsteam an | CI |
| 24.11. | NATCO Pharma erhält sieben Beanstandungen bei US-FDA-Inspektion im API-Werk Chennai | MT |
Hauptkonkurrenten
| Dividendenrendite (Y) | Dividendenrendite (Y+1) | KGV (Y) | Price to Book (Y) | EV / Sales (Y) | Marktkap. / EBITDA (Y) | Marktkap. / EBIT (Y) | Kap.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 0.84% | 0.56% | 11.9x | 1.78x | - | - | - | 1.73 Mrd. | ||
| 0.6% | 0.67% | 43.44x | 32.71x | 14.39x | 31.93x | 34.3x | 890 Mrd. | ||
| 2.5% | 2.58% | 19.71x | 6.33x | 5.53x | 15.3x | 16.78x | 498 Mrd. | ||
| 2.9% | 3.02% | 52.56x | 3781.36x | 7.45x | 17.64x | 18.16x | 398 Mrd. | ||
| 3.07% | 3.13% | 18.69x | 6.67x | 4.69x | 11.75x | 13.32x | 343 Mrd. | ||
| 1.79% | 1.89% | 27.13x | 6.12x | 5.14x | 15.25x | 16.04x | 279 Mrd. | ||
| 3.11% | 3.24% | 18.12x | 5.68x | 4.91x | 11.54x | 12.43x | 252 Mrd. | ||
| 3.31% | 3.35% | 12.62x | 4.5x | 4.13x | 8.83x | 9.97x | 242 Mrd. | ||
| 3.76% | 3.69% | 13.4x | 7.28x | 4.8x | 9.95x | 11.5x | 214 Mrd. | ||
| 3.03% | 3.2% | 24.85x | 19.05x | 5.9x | 10.14x | 13.55x | 170 Mrd. | ||
| 2.73% | 2.85% | 17.7x | 6.64x | 5.59x | 10.22x | 12.29x | 151 Mrd. | ||
| 6.61% | 6.75% | 13.35x | 1.62x | 2.99x | 7.53x | 8.68x | 147 Mrd. | ||
| 5.03% | 5.21% | 11.91x | 1.29x | 2.59x | 8.42x | 9.36x | 117 Mrd. | ||
| -.--% | -.--% | 28.63x | 6.04x | 8.65x | 18.69x | 19.41x | 113 Mrd. | ||
| 4.83% | 4.97% | 12.07x | 5.26x | 2.86x | 8.31x | 8.68x | 104 Mrd. | ||
| 3.61% | 3.87% | 12.87x | 5.05x | 2.66x | 7.84x | 8.99x | 96.53 Mrd. | ||
| 3.11% | 1.59% | 31.3x | 6.81x | 10.08x | 19.72x | 21.09x | 85.78 Mrd. | ||
| 0.44% | 0.5% | 47.78x | 6.99x | 11.55x | 38.01x | 39.98x | 59.61 Mrd. | ||
| -.--% | -.--% | 176.93x | 63.9x | 13.84x | 91.41x | 88.48x | 53.43 Mrd. | ||
| Durchschnitt | 2.7% | 2.69% | 31.31x | 209.21x | 6.54x | 19.03x | 20.17x | 221.8 Mrd. | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | 2.49% | 2.55% | 29.62x | 369.23x | 7.41x | 18.14x | 19.60x |
- Börse
- Aktien
- A2ABRD Aktie
- Sektor NATCO Pharma Limited
- branchenspezifische Dividenden
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
MarketScreener is also available in this country: United States.
Switch edition
Bei der aktuellen länderspezifischen Edition bleiben
















